NapsinA

NapsinA
  • 文章类型: English Abstract
    Objective: To investigate the value of predicting the degree of differentiation of pulmonary invasive adenocarcinoma (IAC) based on CT image radiomics model and the expression difference of immunohistochemical factors between different degrees of differentiation of lesions. Methods: The clinicopathological data of patients with pulmonary IAC confirmed by surgical pathology in the Affiliated Huai\'an First People\'s Hospital to Nanjing Medical University from December 2017 to September 2018 were collected. High-throughput feature acquisition was performed for all outlined regions of interest, and prediction models were constructed after dimensionality reduction by the minimum absolute shrinkage operator. Receiver operating characteristic curve was used to assess the predictive efficacy of clinical characteristic model, radiomics model and individualized prediction model combined with both to identify the degree of pulmonary IAC differentiation, and immunohistochemical expressions of Ki-67, NapsinA and TTF-1 were compared between groups with different degrees of IAC differentiation using rank sum test. Results: A total of 396 high-throughput features were extracted from all IAC lesions, and 10 features with high generalization ability and correlation with the degree of IAC differentiation were screened. The mean radiomics score of poorly differentiated IAC in the training group (1.206) was higher than that of patients with high and medium differentiation (0.969, P=0.001), and the mean radiomics score of poorly differentiated IAC in the test group (1.545) was higher than that of patients with high and medium differentiation (-0.815, P<0.001). The differences in gender (P<0.001), pleural stretch sign (P=0.005), and burr sign (P=0.033) were statistically significant between patients in the well and poorly differentiated IAC groups. Multifactorial logistic regression analysis showed that gender and pleural stretch sign were related to the degree of IAC differentiation (P<0.05). The clinical feature model consisted of age, gender, pleural stretch sign, burr sign, tumor vessel sign, and vacuolar sign, and the individualized prediction model consisted of gender, pleural stretch sign, and radiomic score, and was represented by a nomogram. The Akaike information standard values of the radiomics model, clinical feature model and individualized prediction model were 54.756, 82.214 and 53.282, respectively. The individualized prediction model was most effective in identifying the degree of differentiation of pulmonary IAC, and the area under the curves (AUC) of the individualized prediction model in the training group and the test group were 0.92 (95% CI: 0.86-0.99) and 0.88 (95% CI: 0.74-1.00, respectively). The AUCs of the radiomics group model for predicting the degree of differentiation of pulmonary IAC in the training group and the test group were 0.91 (95% CI: 0.83-0.98) and 0.87 (95% CI: 0.72-1.00), respectively. The AUCs of the clinical characteristics model for predicting the degree of differentiation of pulmonary IACs in the training and test groups were 0.75 (95% CI: 0.63-0.86) and 0.76 (95% CI: 0.59-0.94), respectively. The expression level of Ki-67 in poorly differentiated IAC was higher than that in well-differentiated IAC (P<0.001). The expression levels of NapsinA, TTF-1 in poorly differentiated IAC were higher than those in well-differentiated IAC (P<0.05). Conclusions: Individualized prediction model consisted of gender, pleural stretch sign and radiomics score can discriminate the differentiation degree of IAC with the best performance in comparison with clinical feature model and radiomics model. Ki-67, NapsinA and TTF-1 express differently in different degrees of differentiation of IAC.
    目的: 探讨基于CT图像影像组学列线图模型预测肺浸润性腺癌(IAC)分化程度的价值及免疫组化因子在肿瘤不同分化程度间的表达差异。 方法: 收集2017年12月至2018年9月南京医科大学附属淮安第一医院经手术病理证实为肺IAC患者的临床病理资料。对所有勾画感兴趣区进行高通量特征采集,经最小绝对收缩算子降维处理后构建预测模型。采用受试者工作特征曲线评估临床特征模型、影像组学模型及两者联合的个体化预测模型鉴别肺IAC分化程度的预测效能,免疫组化Ki-67、NapsinA、甲状腺转录因子1(TTF-1)在IAC不同分化程度的组间比较采用秩和检验。 结果: 全组IAC病灶中共提取出396个高通量特征,筛选出10个泛化能力较高、与IAC分化程度相关的特征。训练组低分化IAC的影像组学评分平均值(1.206)高于中高分化患者(0.969,P=0.001),测试组低分化IAC的影像组学评分平均值(1.545)高于中高分化患者(-0.815,P<0.001)。中高分化IAC组和低分化IAC组患者的性别(P<0.001)、胸膜牵拉征(P=0.005)、毛刺征(P=0.033)差异均有统计学意义。多因素logistic回归分析显示,性别、胸膜牵拉征与IAC分化程度有关(均P<0.05)。临床特征模型由年龄、性别、胸膜牵拉征、毛刺征、肿瘤血管征、空泡征组成,个体化预测模型由性别、胸膜牵拉征及影像组学评分构成,并由列线图表示。影像组学模型、临床特征模型和个体化预测模型的Akaike信息标准值分别为54.756、82.214和53.282。个体化预测模型对鉴别肺IAC分化程度的效能最高,个体化预测模型在训练组和测试组中的曲线下面积(AUC)分别为0.92(95% CI:0.86~0.99)和0.88(95% CI:0.74~1.00);影像组模型在训练组和测试组中预测肺IAC分化程度的AUC分别为0.91(95% CI:0.83~0.98)和0.87(95% CI:0.72~1.00);临床特征模型在训练组和测试组中预测肺IAC分化程度的AUC分别为0.75(95% CI:0.63~0.86)和0.76(95% CI:0.59~0.94)。Ki-67在低分化IAC中的表达水平高于中高分化IAC(P<0.001),NapsinA、TTF-1在中高分化IAC中的表达高于低分化IAC(均P<0.05)。 结论: 由性别、胸膜牵拉征及影像组学评分构建的个体化预测模型对浸润性肺腺癌的分化程度具有较高的鉴别效能。Ki-67、NapsinA、TTF-1在浸润性肺腺癌不同分化程度间的表达不同。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    原发性腹膜恶性肿瘤是例外。其中,透明细胞癌极为罕见,自1990年以来,文献中只有13例。我们报告了一名48岁的白人妇女在阿利坎特大学总医院接受治疗的病例。在过去的七个月中,由于进行性腹痛,她进行了咨询,初步诊断为肾输尿管绞痛。腹部和骨盆的超声和计算机断层扫描显示25×15厘米,明确的囊性病变伴乳头状突起,位于腹部的中央。放射学报告建议将原发性卵巢肿瘤与腹膜植入物作为首选。该患者接受了剖腹探查术,显示膀胱腹膜内有大的囊性肿块,牢牢地附着在肠系膜上。整个腹部肿瘤被完全切除,并进行了全子宫切除术,双侧附件卵巢切除术和结肠下网膜切除术。最终的组织学研究显示,位于膀胱腹膜的原发性腹膜透明细胞癌的新病例,牢牢地附着在肠系膜上。严重的,它是完整的,多囊性,乳头状生长累及部分内壁。微观上,它显示肾小管囊性和乳头状模式,具有高度不典型的肿瘤细胞。经过广泛的免疫组织化学分析,最相关的发现是ARID1A丢失,通过显示ARID1A缺失的分子分析得到证实.患者接受卡铂和紫杉醇方案的全身化疗(5~4个周期)。第8个月后的患者随访显示,腹膜植入物主要位于右diaphragm肌,经组织学证实为复发。她刚刚接受了另外六个周期的卡铂和紫杉醇化疗。在这个不常见的位置识别原发性腹膜透明细胞癌,排除卵巢转移,代表了一个诊断挑战.
    Primary peritoneal malignant tumors are exceptional. Among them, clear cell carcinoma is extremely rare, being only thirteen cases previously reported in the literature since 1990. We report a case of a 48-year-old Caucasian woman who was treated at the University General Hospital of Alicante. She consulted because of progressive abdominal pain over the last seven months, with the initial diagnosis of renal-ureteral colic. Ultrasound and computed tomography of the abdomen and pelvis revealed a 25 × 15 cm, well-defined cystic lesion with papillary projections, centrally located in the abdomen. The radiology report suggested a primary ovarian tumor versus peritoneal implant as the first option. The patient underwent an exploratory laparotomy showing a large cystic mass located in the urinary bladder peritoneum, firmly attached to the mesentery. The entire abdominal tumor was completely excised, and total hysterectomy with bilateral salpingo-oophorectomy and infra-colical omentectomy were performed. The final histological study revealed a new case of primary peritoneal clear cell carcinoma located in the urinary bladder peritoneum, firmly attached to the mesentery. Grossly, it was well-circumscribed and multicystic with papillary growth involving part of the inner wall. Microscopically, it showed tubulocystic and papillary patterns with highly atypical tumor cells. After an extensive immunohistochemical analysis, the most relevant finding was an ARID1A loss that was corroborated by molecular analysis showing an ARID1A deletion. The patient received systemic chemotherapy with carboplatin and paclitaxel protocol (Å ~ 4 cycles). Patient follow-up after the eighth month showed peritoneal implants predominantly in the right diaphragmatic cupule that were histologically confirmed as recurrence. She has just received another six cycles of chemotherapy with carboplatin and paclitaxel. Recognition of primary peritoneal clear cell carcinoma in this uncommon location, and exclude metastasis from the ovary, represents a diagnostic challenge.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    BACKGROUND: Alpha-methylacyl-coenzyme A racemase (AMACR, P504S) is a commonly used marker in immunohistochemical diagnosis of prostate cancer. Recent studies identified P504S markers of the clear cell histotype in the ovary and/or endometrium. Gastric-type adenocarcinoma (GAS) is difficult to diagnose histologically, particularly when there is crossover with clear cell carcinoma (CCC). However, the significance of P504S for differentially diagnosing GAS and CCC is unclear.
    OBJECTIVE: To evaluate P504S as a potential diagnostic marker of GAS and CCC.
    METHODS: We analyzed P504S expression in 48 cervical carcinomas (32 GAS and 16 CCC), as well as the expression of other markers including hepatocyte nuclear factor-1 beta (HNF-1β) and NapsinA.
    METHODS: The expression differences of HNF-1β, NapsinA, and P504S in GAS and CCC were detected by immunohistochemistry. Immunohistochemical histoscores based on the intensity and extent of staining were calculated.
    RESULTS: The positive rates of HNF-1β in GAS and CCC were 90.32% and 75%, respectively. (χ2 = 2.251, P = 0.663). The positive rates of NapsinA in GAS and CCC were 19.36% and 81.25%, respectively. (χ2 = 47.332, P < 0.01). The positive rates of P504S in GAS and CCC were 16.13% and 81.25%, respectively. (χ2 = 41.420, P < 0.01). HNF-1β was frequently expressed in GAS and CCC, while NapsinA and P504S were frequently expressed in CCC, and reduced or lost in GAS.
    CONCLUSIONS: NapsinA and P504S can be used to differentiate between GAS and CCC.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号